Elevated EMAP-II levels reflect endothelial dysfunction in type 1 diabetes and correlate with altered carbohydrate and lipid metabolism.
Answers are grounded in this paper and cite their sources.
EMAP-II may mark endothelial dysfunction in type 1 diabetes; leaves open its value for complication prediction or monitoring.
Was investigated serum level of endothelial monocyte activating peptide II (EMAP-II) and endothelium-dependent dilatation in type 1 diabetes and possible relation between those. We found an increase serum level of EMAP-II and decrease of endothelium-dependent dilatation in type 1 diabetes. It was significant correlation between EMAP-II and HbAc1, blood glucose, total cholesterol, LDL, triglycerides and inverse correlation between EMAP-II and HDL, endotheliumdependent dilatation. The revealed change of EMAP-II serum level reflects an endothelial dysfunction in type 1 diabetes, alteration of carbohydrate and lipid metabolism could influence of this pathway.
No takes yet. Share an insight, caveat, or question.
Mogylnytska et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: